AONC (American Oncology Network) Current Deferred Revenue: $0 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AONC American Oncology Network Inc AONC
20 GF Score
Price $10.00
View Full Analysis

What is American Oncology Network Current Deferred Revenue?

American Oncology Network AONC 20 Current Deferred Revenue is $0 Mil as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

American Oncology Network's current deferred revenue for the quarter that ended in Dec. 2024 was $0 Mil.

American Oncology Network Current Deferred Revenue Related Terms

American Oncology Network Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for American Oncology Network's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network Current Deferred Revenue Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
0.00 0.00 0.00 0.00 0.00

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AONC
20GF Score
American Oncology Network Inc AONC
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0 Mil mean?
American Oncology Network (AONC) has a Current Deferred Revenue of $0 Mil as of Dec. 2024. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on American Oncology Network and its competitors.
Is American Oncology Network's Current Deferred Revenue too high?
American Oncology Network's current Current Deferred Revenue is $0 Mil. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's Current Deferred Revenue compare to TOI and AUNA?
American Oncology Network's Current Deferred Revenue of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on American Oncology Network and its competitors. American Oncology Network's current Current Deferred Revenue is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current Current Deferred Revenue of $0 Mil. The current Current Deferred Revenue is $0 Mil. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For American Oncology Network (AONC), the current Current Deferred Revenue is $0 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.00
Price